NASDAQ:AKER Akers Biosciences (AKER) Stock Price, News & Analysis → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free AKER Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$2.12▼$2.2050-Day Range$2.47▼$4.5952-Week Range$1.65▼$6.97Volume36,060 shsAverage Volume769,876 shsMarket Capitalization$36.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesTrendsStock AnalysisCompetitorsHeadlinesTrends Get Akers Biosciences alerts: Email Address Ad Gold Safe ExchangeGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing demand from Central Banks and billionaires to EXPLODE! The elites are buying up gold like nothing we've seen before… Click here now to download the free Precious Metals Buying Guide. About Akers Biosciences Stock (NASDAQ:AKER)Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York.Read More Ad Gold Safe ExchangeGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing demand from Central Banks and billionaires to EXPLODE! The elites are buying up gold like nothing we've seen before… Click here now to download the free Precious Metals Buying Guide. AKER Stock News HeadlinesMay 21, 2024 | msn.comRaymond Akers challenging Oregon House District 57 Rep. Greg Smith in GOP primary electionMay 16, 2024 | msn.comPolice Superintendent Akers fights against retirement requirementMay 15, 2024 | sports.yahoo.comSoccer legend Michelle Akers in KC for Women’s Construction Industry CelebrationMay 6, 2024 | usatoday.comMichigan State women sit in 6th after first day of NCAA regional at Forest AkersApril 16, 2024 | msn.comSpringfield Police Superintendent Akers looks to connect with youthApril 10, 2024 | msn.comLawrence Akers sworn-in as Springfield’s next police superintendentApril 10, 2024 | msn.comOil spillage on Akers Way after bus crash closes roadMarch 25, 2024 | msn.comBetsy Akers reveals $35M Tuxedo Park mansion as her priciest listing yetMarch 21, 2024 | msn.comWoman charged with causing death of teenager on Akers WayMarch 13, 2024 | msn.comCam Akers Becomes A Free AgentMarch 7, 2024 | msn.comRugby Almanack editor Clive Akers steps down after 30 years at rugby book of recordFebruary 6, 2024 | msn.comAkers Mill reopens, Powers Island unit closed at Chattahoochee River parkJanuary 23, 2024 | health.usnews.comJennifer C. AkersJanuary 17, 2024 | msn.comWill the Vikings Bring Back Restricted Free Agent RB Cam Akers in 2024?January 15, 2024 | msn.comDeputy Chief Lawrence Akers to become next Springfield Police SuperintendentJanuary 9, 2024 | msn.comJB Akers appointed to West Virginia House of DelegatesDecember 11, 2023 | msn.comTom Akers, Lewis Knudsen to perform holiday showNovember 16, 2023 | axios.comChloe Akers: Bringing politics back to the middleNovember 12, 2023 | msn.comCam Akers fined more for 'taunting' than Falcons player was for vicious hitNovember 11, 2023 | msn.comThe NFL fined Cam Akers on the week he tore his Achilles once againNovember 9, 2023 | msn.comWhen Is Cam Akers Coming Back? Fantasy Football Injury Return UpdateNovember 8, 2023 | msn.comCam Akers Dynasty Value: What Is the Vikings RB’s Value Now After His Injury?November 8, 2023 | msn.comVikings put Cam Akers on IR, sign QB Tanner Morgan to practice squadNovember 8, 2023 | cbsnews.comVikings place RB Cam Akers on IR, re-sign QB Tanner Morgan to practice squadNovember 6, 2023 | msn.comFormer Rams running back Cam Akers feared to have torn his Achilles Sunday vs. FalconsSee More Headlines Receive AKER Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akers Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2018Today6/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic Substances Sub-IndustryN/A Current SymbolNASDAQ:AKER CUSIPN/A CIK1321834 Webwww.akersbio.com Phone856 848 8698FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,890,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-87.42% Return on Assets-73.31% Debt Debt-to-Equity RatioN/A Current Ratio9.22 Quick Ratio9.22 Sales & Book Value Annual Sales$1.58 million Price / Sales23.08 Cash FlowN/A Price / Cash FlowN/A Book Value$5.38 per share Price / Book0.41Miscellaneous Outstanding Shares16,653,000Free FloatN/AMarket Cap$36.47 million OptionableNot Optionable Beta0.30 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Christopher C. Schreiber (Age 56)CEO, Pres & Director Comp: $507.62kMr. Ian Rhodes (Age 48)Interim Chief Financial Officer Mr. Gary M. Rauch (Age 65)VP of Fin. & Treasurer Key CompetitorsAlpha TeknovaNASDAQ:TKNOVolitionRxNYSE:VNRXARCA biopharmaNASDAQ:ABIOImmuCellNASDAQ:ICCCAspira Women's HealthNASDAQ:AWHView All Competitors AKER Stock Analysis - Frequently Asked Questions How were Akers Biosciences' earnings last quarter? Akers Biosciences, Inc. (NASDAQ:AKER) announced its quarterly earnings results on Thursday, November, 15th. The medical instruments supplier reported ($0.26) EPS for the quarter. The medical instruments supplier earned $0.56 million during the quarter. What is Thomas A. Nicolette's approval rating as Akers Biosciences' CEO? 3 employees have rated Akers Biosciences Chief Executive Officer Thomas A. Nicolette on Glassdoor.com. Thomas A. Nicolette has an approval rating of 64% among the company's employees. What other stocks do shareholders of Akers Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Akers Biosciences investors own include ImmunoGen (IMGN), Sorrento Therapeutics (SRNE), AVEO Pharmaceuticals (AVEO), Advanced Micro Devices (AMD), Aytu BioPharma (AYTU), Biopharmx (BPMX), Neovasc (NVCN), Micron Technology (MU), Vaxart (VXRT) and Anavex Life Sciences (AVXL). This page (NASDAQ:AKER) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredDouble-Threat Biotech Could Deliver Triple-Digit GainsMost investors haven't heard of this under-the-radar biotech... But it could emerge as one of the premier A...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akers Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akers Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.